syngo DynaPBV BodyEvaluate perfusion for personalized therapy
syngo DynaPBV Body Video
syngo DynaPBV Body
Courtesy: Prof. Vogl, Dept. of Diagnostic and Interventional Radiology, University of Frankfurt, Germany
syngo DynaPBV Body
Courtesy: Prof. Vogl, Dept. of Diagnostic and Interventional Radiology, University of Frankfurt, Germany
syngo DynaPBV Body
Courtesy: Prof. Vogl, Dept. of Diagnostic and Interventional Radiology, University of Frankfurt, Germany
syngo DynaPBV Body Video
syngo DynaPBV Body
Courtesy: Prof. Vogl, Dept. of Diagnostic and Interventional Radiology, University of Frankfurt, Germany
syngo DynaPBV Body
Courtesy: Prof. Vogl, Dept. of Diagnostic and Interventional Radiology, University of Frankfurt, Germany
syngo DynaPBV Body
Courtesy: Prof. Vogl, Dept. of Diagnostic and Interventional Radiology, University of Frankfurt, Germany
syngo DynaPBV Body Video
syngo DynaPBV Body is a 3D functional imaging application that provides physiological information directly in the interventional lab.
The software indicates the distribution of blood in lesions and surrounding tissue by means of color-coded cross-sectional blood volume maps. Based on this blood volume information, physicians can evaluate changes in perfusion caused by treatment or biological processes.
Features & Benefits
Features
- Shows the distribution and amount of blood in lesions
- Allows for blood volume measurements
- Provides physiological information directly in the angio suite
Benefits
- Determine the specific characteristics of each individual lesion
- Observe how tumor perfusion changes as a result of your therapy
- Control the optimal end point of your intervention
syngo DynaPBV Body Workflow
Clinical Use
Case Studies
Preparatory Arteriography for Isolation of the Hepatic Arterial Bed Prior to Radioembolization Therapy - Supported by syngo DynaPBV Body
Courtesy of Bora Peynircioğlu, M.D.,
Associate Professor of Radiology, Department of Radiology, Hacettepe University Hospital, Ankara, Turkey
Transarterial Chemoembolization (TACE) in Multifocal Primary Liver Cancer - Supported by syngo DynaPBV Body
Courtesy of Philippe L. Pereira, M.D., PhD, EBIR, and Kristina Krüger,
Department of Radiology, Minimally Invasive Therapies and Nuclear Medicine,
SLK Clinics GmbH, Heilbronn, Germany
Hepatic Blood Volume Imaging Within Catheter Labs - Supported by syngo DynaPBV Body
Courtesy of Prof. Xu Jianrong, M.D.
Department of Radiology, Renji Hospital, China
Protocols and Sequences
Transarterial chemoembolization of HCC using syngo DynaPBV Body
51-year-old male with Hep C. Hepatocellular BCLC stage A carcinoma (HCC), which is not amenable to radiofrequency (RF) ablation due to its proximity to the gall bladder. Patient is awaiting liver transplant and recommended for TACE treatment.
Scientific Talks and Publications
- Intraprocedural blood volume measurement using C-arm CT as a predictor for treatment response of malignant liver tumours undergoing repetitive transarterial chemoembolization (TACE) (Thomas J. Vogl et al., European Radiology 2015)
- Parenchymal Blood Volume Assessed by C-Arm–Based Computed Tomography in Immediate Posttreatment Evaluation of Drug-Eluting Bead Transarterial Chemoembolization in Hepatocellular Carcinoma (Syha, Roland et al., Invest Radiol 2015)
- Quantitative liver tumor blood volume measurements by a C-arm CT post-processing software before and after hepatic arterial embolization therapy: comparison with MDCT perfusion (Bora Peynircioğlu et al., Diagn Interv Radiol 2015)
- Hepatic Blood Volume Imaging with the Use of Flat-Detector CT Perfusion in the Angiography Suite: Comparison with Results of Conventional Multislice CT Perfusion (Zhi-guo Zhuang et al., JVIR 2014)
General Requirements
System
- Artis Q
- Artis zee
Minimum Software Version
PURE®
Other
Please note: Additional technical prerequisites may apply. Upon receiving your request, your local Siemens representative will clarify whether your system meets the requirements.
Did this information help you?
Thank you.
The statements by Siemens' customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.